Baxter International Inc. (LON:0QK8)
London · Delayed Price · Currency is GBP · Price in USD 28.24
-0.20 (-0.69%)
At close: Jul 16, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Chronic Therapies | - | Log In | Log In | Log In | Log In | Upgrade |
Chronic Therapies Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Medication Delivery | - | Log In | Log In | Log In | Log In | Upgrade |
Medication Delivery Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Clinical Nutrition | - | Log In | Log In | Log In | Log In | Upgrade |
Clinical Nutrition Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Advanced Surgery | 1.10B | Log In | Log In | Log In | Log In | Upgrade |
Advanced Surgery Growth | 3.84% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Acute Therapies | - | Log In | Log In | Log In | Log In | Upgrade |
Acute Therapies Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Patient Support Systems | - | Log In | Log In | Log In | Log In | Upgrade |
Patient Support Systems Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Surgical Solutions | - | Log In | Log In | Log In | Log In | Upgrade |
Surgical Solutions Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Front Line Care | 1.14B | Log In | Log In | Log In | Log In | Upgrade |
Front Line Care Growth | -2.30% | Log In | Log In | Log In | Log In | Upgrade |
Injectables and Anesthesia | 1.37B | Log In | Log In | Log In | Log In | Upgrade |
Injectables and Anesthesia Growth | 0.73% | Log In | Log In | Log In | Log In | Upgrade |
Drug Compounding | 1.04B | Log In | Log In | Log In | Log In | Upgrade |
Drug Compounding Growth | 10.71% | Log In | Log In | Log In | Log In | Upgrade |
Other Revenue (Post-Q2 2023 Reporting) | 67.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Revenue (Post-Q2 2023 Reporting) Growth | 76.71% | Log In | Log In | Log In | Log In | Upgrade |
Infusion Therapies | 4.10B | Log In | Log In | Log In | Log In | Upgrade |
Care & Connectivity Solutions | 1.81B | Log In | Log In | Log In | Log In | Upgrade |
BioPharma Solutions | - | Log In | Log In | Log In | Log In | Upgrade |
BioPharma Solutions Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other Revenue (Pre-Q3 2023 Reporting) | - | Log In | Log In | Log In | Log In | Upgrade |
Other Revenue (Pre-Q3 2023 Reporting) Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | -861.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Medical Products & Therapies Operating Income | 950.00M | Log In | Log In | Log In | Log In | Upgrade |
Medical Products & Therapies Operating Income Growth | -3.49% | Log In | Log In | Log In | Log In | Upgrade |
Healthcare Systems & Technologies Operating Income | 468.00M | Log In | Log In | Log In | Log In | Upgrade |
Healthcare Systems & Technologies Operating Income Growth | 12.79% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals Operating Income | 313.00M | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals Operating Income Growth | -23.98% | Log In | Log In | Log In | Log In | Upgrade |
Kidney Care Operating Income | - | Log In | Log In | Log In | Log In | Upgrade |
Other Operating Income | 18.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Operating Income Growth | 53.33% | Log In | Log In | Log In | Log In | Upgrade |
Other | -861.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
United States | 5.85B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 3.79% | Log In | Log In | Log In | Log In | Upgrade |
Emerging Markets | 1.35B | Log In | Log In | Log In | Log In | Upgrade |
Emerging Markets Growth | -1.08% | Log In | Log In | Log In | Log In | Upgrade |
Rest of World | 3.44B | Log In | Log In | Log In | Log In | Upgrade |
Rest of World Growth | 4.36% | Log In | Log In | Log In | Log In | Upgrade |
Americas | - | Log In | Log In | Log In | Log In | Upgrade |
Americas Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EMEA | - | Log In | Log In | Log In | Log In | Upgrade |
EMEA Growth | - | Log In | Log In | Log In | Log In | Upgrade |
APAC | - | Log In | Log In | Log In | Log In | Upgrade |
APAC Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Hillrom | - | Log In | Log In | Log In | Log In | Upgrade |
Hillrom Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2011 - 2018 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2011 - 2018 |
Americas Operating Income | Log In | Log In | Log In | Log In | Upgrade |
Americas Operating Income Growth | Log In | Log In | Log In | Log In | Upgrade |
EMEA Operating Income | Log In | Log In | Log In | Log In | Upgrade |
EMEA Operating Income Growth | Log In | Log In | Log In | Log In | Upgrade |
APAC Operating Income | Log In | Log In | Log In | Log In | Upgrade |
APAC Operating Income Growth | Log In | Log In | Log In | Log In | Upgrade |
Hillrom Operating Income | Log In | Log In | Log In | Log In | Upgrade |
Hillrom Operating Income Growth | Log In | Log In | Log In | Log In | Upgrade |